Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: Synthesis, formulation, characterization and in vitro drug release
Authors:
- Si-Shen FengSFSi-Shen Feng
- 1 January 2006
- journal article
- Published by Elsevier in Biomaterials
- Vol. 27 (2) , 262-270
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugsBiomaterials, 2005
- Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugsBiomaterials, 2004
- A novel controlled release formulation for the anticancer drug paclitaxel (Taxol®): PLGA nanoparticles containing vitamin E TPGSJournal of Controlled Release, 2003
- Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol®)Journal of Controlled Release, 2002
- Determination of the absolute stereochemistry of vitamin E derived oxa‐spiro compounds by NMR spectroscopyMagnetic Resonance in Chemistry, 2001
- Protein release microparticles based on the blend of poly(d,l-lactic-co-glycolic acid) and oligo-ethylene glycol grafted poly(l-lactide)Journal of Controlled Release, 2001
- Effects of emulsifiers on the controlled release of paclitaxel (Taxol®) from nanospheres of biodegradable polymersJournal of Controlled Release, 2001
- Is Cremophor EL, solvent for paclitaxel, cytotoxic?The Lancet, 1993
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983
- Accumulation of 2-μm latex particles in mouse Peyer's patches during chronic latex feedingCellular and Molecular Life Sciences, 1978